Лумикрас
(Соторасіб)
(120 mg)
(56)
(Таб)
Lumakras, Lumikrass (SOTORASIB) 120 mg 56 tab, Bangladesh mfd.
In Stock
Indications
Lumicras® is used to treat adult patients with advanced stage lung cancer called non-small cell lung cancer (NSCLC) that has spread to other organs.
Lumakras is a targeted therapy designed to target only the mutated KRAS G12C molecules and turn them "off". As a result, tumor cell growth may be slowed and prevented
Lumakras is the first targeted therapy of its kind available for NSCLC lung cancer patients with an advanced disease
-
Commercial name:Лумикрас
-
Сhemical name:Соторасіб
-
Dosage:120 mg
-
Quantity:56
-
Release form:Таб
-
Производитель:Бангладешь
No reviews yet